BPH vs. GNOM

Last updated Jul 14, 2026

BPH (BP p.l.c. ADRhedged ETF) and GNOM (Global X Genomics & Biotechnology ETF) are both exchange-traded funds - BPH is a Energy Equities fund actively managed by Precidian, while GNOM is a Health & Biotech Equities fund tracking the Solactive Genomics Index. BPH is actively managed, while GNOM is passively managed. At a correlation of -0.60, they often move in opposite directions. BPH charges 0.19%/yr vs 0.50%/yr for GNOM.

Performance

BPH vs. GNOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BP p.l.c. ADRhedged ETF (BPH) and Global X Genomics & Biotechnology ETF (GNOM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BPH

• 1D: 4.41%
• 1M: -3.74%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

GNOM

• 1D: -1.84%
• 1M: 13.72%
• 6M: 17.52%
• YTD: 22.46%
• 1Y: 59.27%
• 3Y*: 4.79%
• 5Y*: -9.10%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BPH vs. GNOM - Yearly Performance Comparison

	2026 (YTD)
BPH BP p.l.c. ADRhedged ETF	-3.15%
GNOM Global X Genomics & Biotechnology ETF	19.61%

Correlation

The correlation between BPH and GNOM is -0.60, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (All Time) Calculated using the full available price history since May 26, 2026	-0.60

BPH vs. GNOM - Sectors Allocation Comparison

Sectors	BPH	GNOM
Energy	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Financial Services	-	-
Healthcare	-	99.7%
Industrials	-	-
Real Estate	-	-
Technology	-	0.3%
Utilities	-	-

Return for Risk

BPH vs. GNOM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BPH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

GNOM

GNOM Risk / Return Rank: 77
GNOM Sharpe Ratio Rank: 85
GNOM Sortino Ratio Rank: 84
GNOM Omega Ratio Rank: 73
GNOM Calmar Ratio Rank: 79
GNOM Martin Ratio Rank: 66

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BPH vs. GNOM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BP p.l.c. ADRhedged ETF (BPH) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BPH	GNOM	Difference
Sharpe ratio: Return per unit of total volatility	—	2.17	—
Sortino ratio: Return per unit of downside risk	—	2.96	—
Omega ratio: Gain probability vs. loss probability	—	1.34	—
Calmar ratio: Return relative to maximum drawdown	—	3.28	—
Martin ratio: Return relative to average drawdown	—	9.42	—

Drawdowns

BPH vs. GNOM - Drawdown Comparison

The maximum BPH drawdown since its inception was -15.58%, smaller than the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for BPH and GNOM.

Drawdown Indicators

	BPH	GNOM	Difference
Max Drawdown Largest peak-to-trough decline	-15.58%	-75.00%	+59.42%
Max Drawdown (1Y) Largest decline over 1 year	—	-18.17%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-44.24%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-72.14%	—
Current Drawdown Current decline from peak	-6.41%	-49.39%	+42.98%
Average Drawdown Average peak-to-trough decline	-6.77%	-40.69%	+33.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	6.31%	—

Volatility

Volatility by Period

	BPH	GNOM	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.87%	—
Volatility (6M) Calculated over the trailing 6-month period	—	20.69%	—
Volatility (1Y) Calculated over the trailing 1-year period	28.88%	27.54%	+1.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.88%	33.72%	-4.84%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.88%	34.15%	-5.27%

BPH vs. GNOM - Expense Ratio Comparison

BPH has a 0.19% expense ratio, which is lower than GNOM's 0.50% expense ratio.

Dividends

BPH vs. GNOM - Dividend Comparison

BPH's dividend yield for the trailing twelve months is around 0.52%, less than GNOM's 1.17% yield.

Position	TTM	2025	2024	2023	2022	2021	2020
BPH BP p.l.c. ADRhedged ETF	0.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
GNOM Global X Genomics & Biotechnology ETF	1.17%	1.37%	0.00%	0.00%	0.00%	0.03%	0.14%

Frequently Asked Questions

Can I hold both BPH and GNOM in my portfolio?

BPH and GNOM have a correlation of -0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BPH or GNOM?

On fees, BPH is cheaper at 0.19% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BPH or GNOM?

BPH is cheaper with a 0.19% expense ratio, compared with 0.50% for GNOM.

Which ETF pays a higher dividend yield, BPH or GNOM?

GNOM has the higher dividend yield at 1.17%, compared with 0.52% for BPH.

What is the main difference between BPH and GNOM?

BPH is categorized as Energy Equities, while GNOM is Health & Biotech Equities. They also come from different issuers: Precidian and Global X. Their fees differ too: 0.19% for BPH and 0.50% for GNOM.